Recipharm

Recipharm is your partner through every phase of development, we have experts and capabilities to work with you from API route scouting and synthesis to commercial manufacturing. Whether you're navigating early- or late-stage development or need clinical supply, we're here to ensure seamless progress and high-quality results. What you can expect: NPI support: Efficient product development and tech-transfer ReciPredict: Integrated toolkit that enables data-driven and informed decisions Extensive lab capabilities: Advanced labs and analytical services for reliable results GMP pilot-scale equipment: Flexible capabilities to refine and develop your product Blockbuster manufacturing lines: High-capacity lines, ready for your commercial success We offer scalable capacity and state-of-the-art capabilities tailored to protect and maximize your product's potential—no matter the size or complexity of your project. Let’s discuss how we can support your journey to success! https://lnkd.in/dY3bBZkD #CDMO #ProcessDevelopment #TechTransfer #OSD #FillFinish

In a podcast interview with PharmaSource during CPHI, Jon Reed, Head of Strategic Business Planning at Recipharm, discusses the evolving trends in the pharmaceutical space and how we are addressing our clients' pain points: • Speed to market: With the recent launch of ReciPredict, we can reduce time to market by 3-6 months. • Need for smaller scale production and personalised medicin: We are extending our capabilities with smaller-scale, flexible production lines. • GLP-1 and blockbuster drugs: With large-scale equipment, we can respond to emerging requirements from the industry in both sterile filling and the manufacturing of oral solid dosage forms. Listen to the full podcast to learn more about what the future of pharma looks like: https://lnkd.in/d52VThWY

The oral solid dose (OSD) market is constantly evolving, with new trends and challenges emerging as pharma companies strive to streamline production, enhance efficiency and provide more patient-centric solutions. In a recent interview at CPHI Milan 2024 with Pharmaceutical Technology® Europe, Dr. Uwe Hanenberg, Head of Product Implementation at Recipharm, discussed these evolving trends, highlighting: ✅ The rising demand for highly potent APIs ✅ An increasing focus on oral biologics ✅ A growing reliance on digital solutions. Read our latest insight and watch the interview to learn more about the future of OSD and how CDMOs are adapting to meet these challenges: https://lnkd.in/dVJYUjpZ

We are thrilled to announce Rudolf Hausmann, Ph.D., the lucky winner of the ReciPredict Raffle at our booth during CPHI. The question we asked was “Can you predict how long it takes for the powder to flow through the hourglass?” While Dr. Hausmann made an almost perfect guess, assessment of flowability by just looking at the powder is very difficult. With our platform ReciPredict you can move beyond guessing and rely on science-based facts. ReciPredict provides a full evaluation of your material’s physical attributes, such as flowability, enabling you to gain a deeper understanding of your materials and its behavior. Congratulations to Dr. Hausmann from the whole Recipharm Team!!!!! Learn more about ReciPredict: https://lnkd.in/dHyEyaUi #ReciPredict #CDMO #TechTransfer #DrugDevelopment

Looking for an OSD partner you can trust? We have over 25 years of experience in developing and manufacturing oral solid dose products.   No matter the challenge, our expert team have most likely experienced and overcome it before - making us best placed to assist you with your next OSD project. Across our global network of specialised sites, you get access to the strategic expertise, flexible capacity and diverse capabilities both to meet your current demands and to scale as you grow. Learn how we can support your next OSD project: https://lnkd.in/dygd_5E9 #OSD #CDMO #Recipharm

Selecting the appropriate fill form is a critical decision and it’s best made early in the development process. BFS offers flexibility, cost savings, and a steady supply, making it a strong alternative to standard vials. By incorporating BFS from the outset, you can ensure a smooth, error-free transition from development to commercialisation. In our latest insight we will explore the advantages of BFS over glass vials and how our LAB+ small scale equipment can streamline the development process. Learn more on how we can streamline your development process: https://lnkd.in/dXtUsk32 #BFS #DrugDevelopment #Sterilefillfinish

Quality by Design, simplified ⚙️💡 ReciPredict is an integrated tool kit that enables you to make data-driven, informed decisions by applying data science, digital technology and smallest scale process simulation for the development and manufacture of drug products through a Quality by Design approach at higher speed and lower risk. In the first part of our latest interview series, we hear from Dr. Uwe Hanenberg, Head of Product Implementation as he explains how ReciPredict offers the most efficient way to apply Quality by Design within one holistic platform. Interested to know how ReciPredict can streamline your journey to market? Find out more here: https://lnkd.in/dHyEyaUi #QbD #CDMO #TechTransfer #DrugDevelopment

We had an incredible time at #CPHIMilan, filled with engaging discussions, insightful meetings, invaluable networking and teambuilding! 🤝🎉 Our team had the pleasure of connecting with many of you, sharing ideas 💡, and exploring new opportunities to shape the future of the pharmaceutical industry. 🙌 Looking forward to continuing the conversations and building on the momentum! 🚀 https://lnkd.in/dfU6pRjv #Recipharm #PharmaInnovation #TeamBuilding #CPHI2024 #Networking

CPHI Day 2 is complete - a successful and busy day for the whole team. If you still want to meet, come by booth #7B2 - we look forward to meeting with you. #OneExtraordinaryCDMO #CPHIMilan

All set for CPHI Milan, welcome to our booth #7B2 🎉. We can’t wait to meet you 🤝😊!   #CPHI #PharmaNetworking #PharmaceuticalSolutions #Recipharm #IndustryLeaders #HealthcareTransformation #PharmaIndustry